(Q33719197)

28 July 2017

title

Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study (English)

1 reference

28 July 2017

0 references

invasive aspergillosis

1 reference

1 reference

Popp AI

1

1 reference

28 July 2017

White MH

2

1 reference

28 July 2017

Quadri T

3

1 reference

28 July 2017

Walshe L

4

1 reference

28 July 2017

Armstrong D

5

1 reference

28 July 2017

publication date

1 January 1999

1 reference

International Journal of Infectious Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

3

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

157-160

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

28 July 2017

1 reference

7 January 2021

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Favorable outcome of invasive aspergillosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Therapeutic outcome in invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Itraconazole in the treatment of aspergillosis: a study of 16 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Therapy of Murine Aspergillosis with Amphotericin B in Combination with Rifampin or 5-Fluorocytosine

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

Clinical pharmacokinetics of systemic antifungal drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2899%2990038-3

7 January 2021

10.1016/S1201-9712(99)90038-3

Identifiers

DOI

1 reference

28 July 2017

1 reference